More articles from Letter to the Editor

You have access
Glymphatic Insights in Glioblastoma
ASHWIN KUMARIA and KEYOUMARS ASHKAN

Anticancer Research March 2025, 45 (3) 1301-1303; DOI: https://doi.org/10.21873/anticanres.17517
You have access
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
TAYLOR AMERY, SHAADI TABATABAEI, MAYA SONPATKI, EVAN Y. YU and TOMASZ M. BEER

Anticancer Research May 2024, 44 (5) 2247-2248; DOI: https://doi.org/10.21873/anticanres.17033
Open Access
Dual Role of Stratum Corneum Carotenes/Lycopene Against the Development of Chemotherapy-induced PPE in Patients With Cancer
MAXIM E. DARVIN, JURGEN LADEMANN and SORA JUNG

Anticancer Research April 2024, 44 (4) 1487-1489; DOI: https://doi.org/10.21873/anticanres.16944
Open Access
Novel Insights in Genetic Variant Classification
ANTHOULA CHATZIKYRIAKIDOU

Anticancer Research April 2024, 44 (4) 1799-1802; DOI: https://doi.org/10.21873/anticanres.16980
Open Access
From Mendel to Gene Therapy
SAMANTHA L. JEFFREY, DON A. BRIGHAM, SANT P. CHAWLA, NOAH FEDERMAN, FREDERICK L. HALL and ERLINDA M. GORDON

Anticancer Research October 2023, 43 (10) 4257-4261; DOI: https://doi.org/10.21873/anticanres.16620
Open Access
Letter to the Editor: RE: de Gruijl and Armstrong: Cutaneous Melanoma: Sheep in Wolves Clothing? Anticancer Res 42(10): 5021-5025, 2022
ABEL JARELL and NEIL FERNANDES

Anticancer Research April 2023, 43 (4) 1873-1874; DOI: https://doi.org/10.21873/anticanres.16343

Main menu